| Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy (NCT03912766) | Medical University of Lodz | 2016-02-01 |
| Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH (NCT02972268) | Jeil Pharmaceutical Co., Ltd. | 2016-02-01 |
| Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck Contracture (NCT02869061) | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 2016-01-01 |
| Study to Compare the Safety and Pharmacokinetics of CKD-397 (NCT02645890) | Chong Kun Dang Pharmaceutical | 2015-11-01 |
| The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil (NCT03144596) | Kocatepe University | 2015-10-29 |
| Prospective Controlled Randomized Study of PAE vs TURP for BPH Treatment. (NCT02566551) | Group of Research in Minimally Invasive Techniques | 2015-10-01 |
| Safety and Efficacy of OCL 503 in Prostate Artery Embolization (NCT02509975) | IMBiotechnologies Ltd. | 2015-09-01 |
| Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction (NCT01967251) | Takeda | 2015-09-01 |
| Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients (NCT03246880) | Chong Kun Dang Pharmaceutical | 2015-09-01 |
| The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. (NCT02494349) | Jeil Pharmaceutical Co., Ltd. | 2015-08-01 |
| Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients. (NCT02524236) | Beni-Suef University | 2015-08-01 |
| Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells (NCT02425800) | Wake Forest University Health Sciences | 2015-07-28 |
| A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS). (NCT02431754) | Eli Lilly and Company | 2015-04-01 |
| A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules (NCT02667938) | Hanmi Pharmaceutical Company Limited | 2015-03-01 |
| Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia (NCT02977832) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2015-01-01 |
| AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia (NCT03167294) | PROCEPT BioRobotics | 2014-12-14 |
| Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams (NCT02167009) | Tampa General Hospital | 2014-12-01 |
| Protocollo N 2014 - Benign Prostatic Hyperplasia (NCT06182189) | IRCCS San Raffaele | 2014-12-01 |
| A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (NCT02326454) | Light Sciences Oncology | 2014-11-01 |
| Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency (NCT02293759) | Mansoura University | 2014-10-01 |
| GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCT (NCT02283684) | Mansoura University | 2014-09-01 |
| Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia (NCT02206243) | Jena University Hospital | 2014-09-01 |
| Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH) (NCT02167919) | University of North Carolina, Chapel Hill | 2014-07-01 |
| GreenLight XPS Laser System Retrospective Chart Review (NCT02139969) | Boston Scientific Corporation | 2014-05-01 |
| Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment. (NCT01931605) | University Hospital, Rouen | 2014-05-01 |
| Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin (NCT02239484) | Hanmi Pharmaceutical Company Limited | 2014-03-01 |
| Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms. (NCT01963312) | Fundacion Miguel Servet | 2014-03-01 |
| Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS (NCT02303769) | GL Pharm Tech Corporation | 2014-03-01 |
| Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia (NCT02054013) | Daniel Stephan Engeler | 2014-02-11 |
| Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study (NCT02051036) | JUNGNAM KWON | 2014-02-01 |
| Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia (NCT02106182) | JW Pharmaceutical | 2014-01-02 |
| Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia (NCT02313233) | Golden Biotechnology Corporation | 2013-12-01 |
| Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode (NCT02019030) | Olympus Corporation of the Americas | 2013-12-01 |
| Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System (NCT02029560) | JW Pharmaceutical | 2013-11-01 |
| Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH (NCT01966614) | Sophiris Bio Corp | 2013-10-01 |
| Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia (NCT01939184) | Warner Chilcott | 2013-08-01 |
| Prostate Embolization for Benign Prostatic Hyperplasia (NCT01924988) | James B. Spies, MD | 2013-08-01 |
| Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2) (NCT01534351) | Merck Sharp & Dohme LLC | 2013-08-01 |
| Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) (NCT01912339) | Boston Scientific Corporation | 2013-07-01 |
| Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia (NCT01789840) | Merit Medical Systems, Inc. | 2013-07-01 |
| Application of DWI in Diagnosis of Prostate Cancer (NCT04962269) | Peking University Third Hospital | 2013-06-12 |
| 2013 Annual National Digital Rectal Exam (DRE) Day Study (NCT01886547) | St. Luke's Medical Center, Philippines | 2013-06-01 |
| The Changes of Urine Growth Factors Level (NCT06282731) | En Chu Kong Hospital | 2013-05-31 |
| Analysis of Prostatic Arterial Embolization for Benign Prostatic Hyperplasia Using Embosphere Microspheres (NCT02679430) | Antonios Likourezos | 2013-05-01 |
| JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) (NCT01830829) | Dr. J. Curtis Nickel | 2013-04-01 |
| UroLift System TOlerability and ReCovery When Administering Local Anesthesia (NCT01876706) | NeoTract, Inc. | 2013-04-01 |
| Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) (NCT01846793) | Nymox Corporation | 2013-04-01 |
| Ultrasound-Guided Photoselective Vaporization of the Prostate (NCT02346500) | Johns Hopkins University | 2012-12-01 |
| Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression (NCT01716104) | Materia Medica Holding | 2012-11-01 |
| Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels (NCT01678313) | Buddhist Tzu Chi General Hospital | 2012-08-01 |
| Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS (NCT01589263) | VA Office of Research and Development | 2012-06-01 |
| Rezum FIM Optimization Study (NCT02940392) | Boston Scientific Corporation | 2012-03-19 |
| Rezum I Pilot Study for Benign Prostatic Hyperplasia (NCT02943070) | Boston Scientific Corporation | 2012-03-01 |
| BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia (NCT01533038) | NeoTract, Inc. | 2012-02-01 |
| QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser) (NCT01534793) | Assistance Publique - Hôpitaux de Paris | 2012-02-01 |
| Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia (NCT06380062) | Universität des Saarlandes | 2012-01-12 |
| Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) (NCT01454349) | Sophiris Bio Corp | 2011-09-01 |
| Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (NCT01438775) | Nymox Corporation | 2011-09-01 |
| Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH) (NCT01404637) | Samsung Medical Center | 2011-07-01 |
| Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon (NCT01604148) | Samsung Medical Center | 2011-07-01 |
| Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia (NCT01757769) | RECORDATI GROUP | 2011-05-01 |
| Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPH (NCT01218672) | Boston Scientific Corporation | 2011-04-01 |
| BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) (NCT01520441) | The University of Texas Health Science Center, Houston | 2011-03-01 |
| 3D Recording of a Trans-rectal Prostate Biopsy (NCT01314456) | HaEmek Medical Center, Israel | 2011-03-01 |
| The Safety and Effectiveness of UroLift: LIFT Pivotal Study (NCT01294150) | NeoTract, Inc. | 2011-02-01 |
| Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) (NCT01002222) | Health Ever Bio-Tech Co., Ltd. | 2011-01-01 |
| Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH) (NCT01301599) | Samsung Medical Center | 2011-01-01 |
| Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome (NCT01826617) | St. Luke's Medical Center, Philippines | 2010-12-01 |
| Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH) (NCT01259531) | JW Pharmaceutical | 2010-12-01 |
| An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL (NCT01351987) | Taipei Medical University WanFang Hospital | 2010-12-01 |
| A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms (NCT01139762) | Eli Lilly and Company | 2010-09-01 |
| A Study in Benign Prostatic Hyperplasia (NCT01152190) | Eli Lilly and Company | 2010-09-01 |
| Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (NCT01107392) | Allergan | 2010-08-01 |
| Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy (NCT01435954) | GlaxoSmithKline | 2010-08-01 |
| Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (NCT01002274) | Health Ever Bio-Tech Co., Ltd. | 2010-08-01 |
| MCS in the Treatment of Lower Urinary Tract Symptoms (NCT01002417) | Health Ever Bio-Tech Co., Ltd. | 2010-07-01 |
| Korean Practice Patterns for Screening PCA(Prostate Cancer) (NCT01371513) | GlaxoSmithKline | 2010-05-01 |
| Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (NCT01002664) | Health Ever Bio-Tech Co., Ltd. | 2010-05-01 |
| Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms (NCT01021332) | Astellas Pharma Europe B.V. | 2010-04-26 |
| A Study in Men With Benign Prostatic Hyperplasia (NCT01097707) | Eli Lilly and Company | 2010-04-01 |
| Transurethral Ventral Wall of Urethra-preserving Enucleation of Prostate (NCT01073241) | Southwest Hospital, China | 2010-03-01 |
| Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (NCT01018511) | Astellas Pharma Europe B.V. | 2010-01-11 |
| Economic Analyses of the REDUCE Trial (NCT01337258) | GlaxoSmithKline | 2010-01-01 |
| A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia (NCT00894517) | Allergan | 2009-08-01 |
| Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg (NCT00954889) | Samsung Medical Center | 2009-08-01 |
| Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia (NCT00962390) | Ausio Pharmaceuticals, LLC | 2009-06-01 |
| Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) (NCT00918034) | Light Sciences Oncology | 2009-05-01 |
| Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (NCT00918983) | Nymox Corporation | 2009-04-01 |
| Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia (NCT00861757) | Eli Lilly and Company | 2009-03-01 |
| EC905 Pharmacokinetic Profile Study (NCT02634489) | Astellas Pharma Europe B.V. | 2009-03-01 |
| A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia (NCT00855582) | Eli Lilly and Company | 2009-03-01 |
| A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers (NCT00848081) | Eli Lilly and Company | 2009-03-01 |
| Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily (NCT00827242) | Eli Lilly and Company | 2009-01-01 |
| Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia (NCT00889707) | Sophiris Bio Corp | 2009-01-01 |
| Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto (NCT00797394) | innoVactiv Inc. | 2008-11-01 |
| Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension (NCT00783094) | Eli Lilly and Company | 2008-11-01 |
| Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH (NCT00877669) | Samsung Medical Center | 2008-10-01 |
| Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia (NCT00771394) | Astellas Pharma Inc | 2008-10-01 |
| Temperature Mapping of the Prostate With the Wallterm™ System (NCT00662350) | Pnn Medical A/S | 2008-06-01 |
| Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) (NCT00709488) | Light Sciences Oncology | 2008-06-01 |